Indian Journal of Pain

CASE REPORT
Year
: 2022  |  Volume : 36  |  Issue : 2  |  Page : 100--102

Celiac plexus chemical neurolysis for refractory pain associated with superior mesenteric artery syndrome


Ravi Shankar Sharma1, Ajit Kumar1, Girish Kumar Singh1, Sonal Goyal1, Suyashi Sharma2 
1 Department of Anaesthesiology, AIIMS, Rishikesh, Uttarakhand, India
2 Senior Resident, Department of Anatomy, Aiims, Jodhpur, India

Correspondence Address:
Dr. Girish Kumar Singh
Department of Anaesthesiology, AIIMS, Rishikesh - 249 203, Uttarakhand
India

Superior mesenteric artery (SMA) syndrome is caused by the compression of a part of the intestine between the aorta and SMA. It may lead to severe epigastric pain that is even refractory to conservative and surgical forms of therapy. Celiac plexus chemical neurolysis has been used in the past for debilitating pain associated with upper gastrointestinal malignancies and chronic pancreatitis. However, to date, this intervention has never been described in the literature for managing pain in SMA syndrome patients. Here, we describe the case of SMA syndrome whose pain was successfully managed with celiac plexus chemical neurolysis.


How to cite this article:
Sharma RS, Kumar A, Singh GK, Goyal S, Sharma S. Celiac plexus chemical neurolysis for refractory pain associated with superior mesenteric artery syndrome.Indian J Pain 2022;36:100-102


How to cite this URL:
Sharma RS, Kumar A, Singh GK, Goyal S, Sharma S. Celiac plexus chemical neurolysis for refractory pain associated with superior mesenteric artery syndrome. Indian J Pain [serial online] 2022 [cited 2022 Nov 29 ];36:100-102
Available from: https://www.indianjpain.org/article.asp?issn=0970-5333;year=2022;volume=36;issue=2;spage=100;epage=102;aulast=Sharma;type=0